Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.40% | 14.98% | 25.71% | -0.49% | 21.19% |
| Total Depreciation and Amortization | -9.17% | -12.11% | -10.15% | -0.12% | 27.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,638.80% | -12.90% | -83.37% | 146.91% | -96.89% |
| Change in Net Operating Assets | -114.60% | -64.49% | 9.11% | 231.57% | 22.76% |
| Cash from Operations | -14.25% | 8.39% | 20.99% | 35.75% | 13.60% |
| Capital Expenditure | 88.97% | 99.80% | 99.78% | 99.91% | 94.30% |
| Sale of Property, Plant, and Equipment | -31.43% | -42.86% | -42.86% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 206.60% |
| Cash from Investing | -100.64% | -99.88% | -99.89% | 100.76% | 138.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 72.94% | 25.81% |
| Issuance of Common Stock | 8,465.28% | 5,430.89% | 5,430.89% | -50.38% | -51.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10,092.68% | 6,449.88% | 6,797.30% | 172.61% | -16.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 127.56% | 229.73% | 157.42% | 56.10% | 79.91% |